NL1030503A1 - Octahydropyrrolo [3,4-c] pyrrole derivatives. - Google Patents

Octahydropyrrolo [3,4-c] pyrrole derivatives.

Info

Publication number: NL1030503A1
Authority: NL; Netherlands
Prior art keywords: octahydropyrrolo; pyrrole derivatives; pyrrole; derivatives
Prior art date: 2004-11-24

Application number

NL1030503A

Other languages

Dutch (nl)

Other versions

NL1030503C2 (en

Inventor

Charlotte Alice Louise Lane

David Anthony Price

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-11-24

Filing date

2005-11-23

Publication date

2006-05-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35985757&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL1030503(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-11-24 Priority claimed from EP04106044A external-priority patent/EP1671972A1/en

2005-11-23 Application filed by Pfizer filed Critical Pfizer

2006-05-29 Publication of NL1030503A1 publication Critical patent/NL1030503A1/en

2006-11-28 Application granted granted Critical

2006-11-28 Publication of NL1030503C2 publication Critical patent/NL1030503C2/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Reproductive Health (AREA)
Immunology (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NL1030503A 2004-11-24 2005-11-23 Octahydropyrrolo [3,4-c] pyrrole derivatives. NL1030503C2 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP04106044A EP1671972A1 (en)	2004-11-24	2004-11-24	Octahydropyrrolo[3,4-c]pyrrole derivatives
EP04106044		2004-11-24
EP05100474		2005-01-26
EP05100474		2005-01-26

Publications (2)

Publication Number	Publication Date
NL1030503A1 true NL1030503A1 (en)	2006-05-29
NL1030503C2 NL1030503C2 (en)	2006-11-28

Family

ID=35985757

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL1030503A NL1030503C2 (en)	2004-11-24	2005-11-23	Octahydropyrrolo [3,4-c] pyrrole derivatives.

Country Status (12)

Country	Link
EP (1)	EP1846409A1 (en)
JP (1)	JP2008520644A (en)
AR (1)	AR054707A1 (en)
CA (1)	CA2587141A1 (en)
GT (1)	GT200500340A (en)
NL (1)	NL1030503C2 (en)
PA (1)	PA8653801A1 (en)
PE (1)	PE20061055A1 (en)
SV (1)	SV2007002315A (en)
TW (1)	TW200626600A (en)
UY (1)	UY29221A1 (en)
WO (1)	WO2006056848A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2627221T3 (en)	2006-12-28	2017-07-27	Rigel Pharmaceuticals, Inc.	N-substituted heterocycloalkyloxybenzamide compounds and methods of use
EP2201982A1 (en)	2008-12-24	2010-06-30	INSERM (Institut National de la Santé et de la Recherche Médicale)	Histamine H4 receptor antagonists for the treatment of vestibular disorders
EP2460794A4 (en) *	2009-07-31	2013-01-23	Shionogi & Co	Pharmaceutical composition containing fused hetero-ring derivative
US8680275B2 (en)	2009-10-23	2014-03-25	Janssen Pharmaceutica Nv	Fused heterocyclic compounds as orexin receptor modulators
US8653263B2 (en)	2009-10-23	2014-02-18	Janssen Pharmaceutica	Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
US9062044B2 (en)	2009-10-23	2015-06-23	Janssen Pharmaceutica Nv	Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
WO2012145581A1 (en)	2011-04-20	2012-10-26	Janssen Pharmaceutica Nv	Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
SI2858647T1 (en)	2012-06-08	2018-11-30	Sensorion	H4 receptor inhibitors for treating tinnitus
BR112018067906A2 (en)	2016-03-10	2019-01-29	Janssen Pharmaceutica Nv	Methods of treating depression using orexin-2 receptor antagonists
WO2019152883A1 (en) *	2018-02-02	2019-08-08	Padforward Llc	Inhibitors of protein arginine deiminases
CN117143245B (en) *	2023-08-28	2025-11-28	杭州旭科生物技术有限公司	Anti-fluoxetine antibodies or antigen binding fragments thereof and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2620341A (en) *	1949-03-24	1952-12-02	Burroughs Wellcome Co	N,n-dialkyl-quinoline-4-carboxamidines
CA2218088A1 (en) *	1995-05-11	1996-11-14	Pharmacia & Upjohn Company	Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
GB9902453D0 (en) *	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
WO2002070523A1 (en) *	2001-03-07	2002-09-12	Pfizer Products Inc.	Modulators of chemokine receptor activity
US6803362B2 (en) *	2001-03-09	2004-10-12	Ortho-Mcneil Pharmaceutical Inc.	Heterocyclic compounds
US7226938B2 (en) *	2002-09-06	2007-06-05	Janssen Pharmaceutica, N.V.	Heterocyclic compounds
CN1694704A (en) *	2002-09-06	2005-11-09	詹森药业有限公司	Use of (1H-benzimidazole-2-yl)-(piperazineyl)- ketaderavitive and correlative compound used as histamine H4 receptor antagonist for the treatment of allergy and asthma
WO2004021999A2 (en) *	2002-09-06	2004-03-18	Janssen Pharmaceutica, N.V.	Use of histamine h4 receptor modulators for the treatment of allergy and asthma

2005
- 2005-11-10 WO PCT/IB2005/003478 patent/WO2006056848A1/en not_active Ceased
- 2005-11-10 EP EP05824102A patent/EP1846409A1/en not_active Withdrawn
- 2005-11-10 JP JP2007542155A patent/JP2008520644A/en active Pending
- 2005-11-10 CA CA002587141A patent/CA2587141A1/en not_active Abandoned
- 2005-11-21 UY UY29221A patent/UY29221A1/en not_active Application Discontinuation
- 2005-11-21 PE PE2005001360A patent/PE20061055A1/en not_active Application Discontinuation
- 2005-11-22 AR ARP050104891A patent/AR054707A1/en unknown
- 2005-11-23 GT GT200500340A patent/GT200500340A/en unknown
- 2005-11-23 TW TW094141134A patent/TW200626600A/en unknown
- 2005-11-23 NL NL1030503A patent/NL1030503C2/en not_active IP Right Cessation
- 2005-11-24 PA PA20058653801A patent/PA8653801A1/en unknown
- 2005-11-24 SV SV2005002315A patent/SV2007002315A/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
UY29221A1 (en)	2006-06-30
CA2587141A1 (en)	2006-06-01
NL1030503C2 (en)	2006-11-28
AR054707A1 (en)	2007-07-11
SV2007002315A (en)	2007-02-16
GT200500340A (en)	2006-07-13
EP1846409A1 (en)	2007-10-24
WO2006056848A1 (en)	2006-06-01
TW200626600A (en)	2006-08-01
JP2008520644A (en)	2008-06-19
PE20061055A1 (en)	2006-11-09
PA8653801A1 (en)	2006-06-02

Publication	Publication Date	Title
PT1761542E (en)	2008-03-26	Octahydropyrrolo[3,4-c]pyrrole derivatives an their use as antiviral agents
DE122012000043I1 (en)	2012-09-13	Pyrrolo [2,3-B] pyridine derivatives as protein kinase inhibitors.
IS8403A (en)	2006-04-07	Pyrrole derivatives with bactericidal activity
NO20053955D0 (en)	2005-08-25	Pyrazolo [1,5-A] pyrimidine derivatives
NL1025068A1 (en)	2004-06-22	Pyrrolopyrimidine derivatives.
ZA200606974B (en)	2008-04-30	Substituted 1,2,3,4-tetrahydrolsoquinoline derivatives
IL183764A0 (en)	2007-09-20	Bicyclic pyrrole derivatives
NO20053748D0 (en)	2005-08-04	Pyrrolopyridazine derivatives.
ZA200805354B (en)	2009-10-28	Aryl-isoxazol-4-yl-imidazo[1,5-A]pyridine derivatives
DK1710241T3 (en)	2010-03-01	Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a, 12b-tetrahydro-1h-dibenz [2,3: 6,7] oxepino [4,5-c] pyrrole
DE602004029045D1 (en)	2010-10-21	PYRROLO [3,4-C] PYRAZOLE DERIVATIVES WITH KINASE-HEMMENDER EFFECT
NO20054330D0 (en)	2005-09-20	8-substituted-6,7,8,9-tetrahydropyrimido [1,2-a] pyrimidin-4-one derivatives
DK1761533T3 (en)	2011-08-08	1-Aza-bicyclo [3.3.1] nonanes
NO20054331D0 (en)	2005-09-20	Substituted-8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido [1,2-a] pyrimidin-4-one derivatives
ZA200506744B (en)	2006-06-28	PyrazoloÄ1,5-AÜpyrimidine derivatives
NL1030503A1 (en)	2006-05-29	Octahydropyrrolo [3,4-c] pyrrole derivatives.
DE602005000528D1 (en)	2007-03-22	The steering lock
AP2501A (en)	2012-10-22	Substituted pyrrole derivatives
BRPI0509256A (en)	2007-09-11	pyrrolidine-3,4-dicarboxamide derivatives
ZA200610587B (en)	2008-08-27	1-Heterocyclyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones
ZA200602947B (en)	2007-09-26	Pyrrol derivatives with antibacterial activity
GB0710111D0 (en)	2007-07-04	Pyrrolo [2, 1-C] [1, 4] benzodiazepine-anthraquinone conjugates useful as antitumour agents
SI1761542T1 (en)	2008-06-30	OCTAHYDROPYRROLO?á3,4-C?åPYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS
HK1103546A (en)	2007-12-21	1-heterocyclyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones
ES1058808Y (en)	2005-06-01	TRAVEL SUITCASE WITH PERFECTED WHEELS.

Legal Events

Date	Code	Title	Description
2006-08-01	AD1A	A request for search or an international type search has been filed
2006-10-02	RD2N	Patents in respect of which a decision has been taken or a report has been made (novelty report)	Effective date: 20060726
2007-02-01	PD2B	A search report has been drawn up
2009-08-03	VD1	Lapsed due to non-payment of the annual fee	Effective date: 20090601